Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

Trial Profile

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Linagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms RELEASE
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 15 Sep 2017 Results assessing effect of linagliptin on plasma levels of nitrate in parallel with the reduction in FDG-PET-assessed arterial inflammation by comparing patients from this trial and young healthy controls, presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
    • 15 Sep 2017 Results (n=44) assessing association between visceral adipose tissue volume and subclinical arterial inflammation presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top